VitaNova Life Sciences (VNOV) Liabilities from Discontinued Operations (2018)

VitaNova Life Sciences (VNOV) posted Liabilities from Discontinued Operations of 5600.0 for Q2 2018.

VitaNova Life Sciences (VNOV) Liabilities from Discontinued Operations (2018) Analysis & Trends

VitaNova Life Sciences' Liabilities from Discontinued Operations history runs 1 years deep, the most recent figure standing at 5600.0 for Q2 2018.

  • Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 5600.0 in Q2 2018, while the trailing twelve-month figure through Apr 2018 was 5600.0 (changed N/A YoY) and the FY2018 annual result came in at 5600.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations was 5600.0 for Q2 2018 at VitaNova Life Sciences.
  • Across five years, Liabilities from Discontinued Operations topped out at 5600.0 in Q2 2018 and bottomed at 5600.0 in Q2 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Mckesson 105.15 Bn 101.18 Bn 4.04 Bn
2 Cencora 60.58 Bn 58.40 Bn 3.59 Bn
3 Cardinal Health 53.81 Bn 49.87 Bn 2.50 Bn
4 Henry Schein 9.71 Bn 9.57 Bn 1.07 Bn
5 Akso Health 3.28 Bn 3.28 Bn -
6 111 651.73 Mn 572.63 Mn 23.58 Mn
7 Accendra Health 248.02 Mn -88.86 Mn 278.03 Mn
8 Edap Tms 230.14 Mn 215.14 Mn 8.15 Mn
9 VitaNova Life Sciences 11.51 Mn 11.01 Mn 316,343.00
10 Cosmos Health 9.57 Mn 7.41 Mn 1.38 Mn

Historic Data

Download Data
DateValue
Apr 30, 2018 5,600.00
Apr 30, 2018 5,600.00